Nephropathy induced by unspecified drug, medicament or biological substance
ICD-10 N14.2 is a billable code used to indicate a diagnosis of nephropathy induced by unspecified drug, medicament or biological substance.
Nephropathy induced by unspecified drug, medicament or biological substance refers to kidney damage resulting from exposure to a drug or biological agent that is not specifically identified. This condition can manifest in various forms, including drug-induced interstitial nephritis, pyelonephritis, and hydronephrosis. The pathophysiology often involves an immune-mediated response or direct tubular toxicity, leading to inflammation and impaired renal function. Patients may present with symptoms such as flank pain, fever, and changes in urination patterns, often accompanied by urinary tract infections (UTIs). Diagnosis typically involves a combination of clinical evaluation, laboratory tests, and imaging studies to assess kidney function and structure. Management may include discontinuation of the offending agent, supportive care, and in some cases, antibiotic therapy to address secondary infections. Understanding the specific drug involved, if possible, is crucial for effective treatment and prevention of further nephrotoxicity.
Detailed patient history including medication use, lab results, and imaging studies.
Patients presenting with acute kidney injury following medication changes or new prescriptions.
Ensure clear documentation of the timeline of drug exposure and renal function tests.
Documentation of any urinary tract infections and their management.
Patients with recurrent UTIs and renal impairment potentially linked to antibiotic use.
Document the relationship between antibiotic use and renal function changes.
Used to evaluate renal function and detect urinary tract infections in patients with suspected nephropathy.
Document the reason for urinalysis and any relevant findings.
Nephrologists may require more detailed lab results to assess kidney function.
Document the patient's complete medication history, any recent changes in medications, clinical symptoms, laboratory results, and imaging studies that indicate nephropathy.
